AbbVie Reports First-Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
AbbVie (ABBV) Tops Q1 EPS by 8c, Raises FY EPS Guidance
April 25, 2019 7:43 AM EDTAbbVie (NYSE: ABBV) reported Q1 EPS of $2.14, $0.08 better than the analyst estimate of $2.06. Revenue for the quarter came in at $7.83 billion versus the consensus estimate of $7.76 billion.
GUIDANCE:
AbbVie sees FY2019 EPS of $8.73-$8.83, versus the consensus of $8.69.
For earnings history and earnings-related data on AbbVie (ABBV) click here.
... More


